Dexco revenue and financials
R$6.89Change from previous close: +1.17%Absolute change: +R$0.08
In the fiscal year ended December 2025, Dexco reported revenue of R$8.25B (+0.17% year over year). Net income was R$1.18M, a net margin of 0.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +0.17%
- 2025 vs 2024
- Net income growth
- −99.31%
- 2025 vs 2024
- Net margin
- 0.0%
- 2024: 2.1%
Financial data
Amounts in millions of BRL; per-share values in BRL; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total assets | 19,087 | 19,675 | 19,001 | — | 17,989 | 17,982 |
| Current assets | 6,422 | 6,735 | 6,048 | — | 4,911 | 4,807 |
| Cash and equivalents | 2,360 | 2,764 | 2,178 | — | 862 | 1,121 |
| Short-term investments | 318 | 367 | 351 | — | 600 | 368 |
| Inventory | 1,783 | 1,740 | 1,713 | — | 1,769 | 1,679 |
| Net property, plant and equipment | 4,920 | 5,107 | 5,154 | — | 5,356 | 5,334 |
| Goodwill | 308 | 407 | 407 | — | 407 | 648 |
| Other intangible assets | 417 | 419 | 426 | — | 437 | 202 |
| Long-term investments | 2,375 | 2,367 | 2,359 | — | 2,410 | 2,373 |
| Current liabilities | 3,236 | 3,291 | 2,701 | — | 4,017 | 3,500 |
| Accounts payable | 1,150 | 1,099 | 1,136 | — | 1,221 | 1,135 |
| Long-term debt | 4,819 | 4,237 | 7,067 | — | 1,474 | 2,616 |
| Total debt | 5,966 | 5,455 | 8,482 | — | 3,008 | 3,979 |
| Total liabilities | 11,683 | 12,303 | 11,793 | — | 10,941 | 10,877 |
| Total equity (incl. minority) | 7,404 | 7,372 | 7,208 | — | 7,047 | 7,105 |
| Minority interest | 481 | 457 | 361 | — | 241 | 233 |